Caribou Biosciences Inc (CRBU) Stock Price, Quote & News

Company Profile

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Ho...

Industry: Biotechnology

Sector: Healthcare

Phone: 510 982 6030

Website: cariboubio.com

Address:

2929 7th Street, Suite 105, Berkeley, United States

Jidane Apr. 3 at 1:42 PM

$CRBU He has come again and just spit anything here.

0 · Reply

HughGeez Apr. 3 at 12:51 PM

$CRBU Although very rocky, CRBU's current trajectory is upward. Hopefully as CRBU rises, the swings will lessen. Right now, this has got to be one of the better stocks to swing trade (not my game, kind of annoying, but this seems to be whats going on).

0 · Reply

HughGeez Apr. 3 at 12:43 PM

$CRBU The funding issue is already certainly built into the extremely low price of this stock. The announcement of a solid funding partner will only contribute to the rise of CRBU.

0 · Reply

Peterson28 Apr. 3 at 1:12 AM

$CRBU Still haven’t figured out the funding issue. One quarter missed already.

0 · Reply

OfficialStocktwitsUser Apr. 2 at 1:33 PM

$CRBU RSI: 51.08, MACD: 0.0249 Vol: 0.08, MA20: 1.90, MA50: 1.76 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

CRSPbacon Apr. 1 at 2:47 AM

$CRBU

0 · Reply

StocksGoddess Mar. 31 at 8:39 PM

$CRBU will rise tomorrow again.

0 · Reply

hughbeefman69 Mar. 31 at 5:49 PM

$CRBU Whatcha mean by this exactly? New to checking out this stock, seems like a quality company with some pretty epic recent news...?

1 · Reply

CebuCity Mar. 31 at 4:10 PM

$CRBU Just looking for a hand out...

0 · Reply

Peterson28 Mar. 31 at 3:52 PM

$CRBU Typical price action. Wall Street just hates the stock. Likely flat by end of the day.

0 · Reply

Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy

Mar 17, 2026, 9:38 AM EDT - 19 days ago

Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value

Mar 5, 2026, 4:05 PM EST - 4 weeks ago

Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 17, 2026, 8:00 AM EST - 6 weeks ago

Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample

Feb 12, 2026, 4:05 PM EST - 7 weeks ago

Caribou Biosciences to Participate in Upcoming Investor Conferences

Feb 4, 2026, 8:00 AM EST - 2 months ago

Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR®

Dec 1, 2025, 4:05 PM EST - 4 months ago

Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025

Nov 12, 2025, 4:05 PM EST - 5 months ago

Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 3, 2025, 11:48 AM EST - 5 months ago

Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today>

Nov 3, 2025, 7:00 AM EST - 5 months ago

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma

Nov 3, 2025, 7:00 AM EST - 5 months ago

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies

Nov 2, 2025, 4:00 PM EST - 5 months ago

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma

Aug 25, 2025, 4:05 PM EDT - 7 months ago

Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference

Aug 12, 2025, 4:05 PM EDT - 8 months ago

Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update

May 28, 2025, 4:00 PM EDT - 11 months ago

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference

May 8, 2025, 4:05 PM EDT - 11 months ago

Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update

May 6, 2025, 4:00 PM EDT - 11 months ago

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

Apr 24, 2025, 4:15 PM EDT - 1 year ago

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

Apr 10, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect

Apr 8, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out

Apr 6, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation

Apr 3, 2025, 10:00 AM EDT - 1 year ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 1, 2025, 10:00 AM EDT - 1 year ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Mar 30, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Investors to Connect

Mar 27, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation

Mar 25, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Investors to Learn More About the Investigation

Mar 20, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Reach Out

Mar 18, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Connect

Mar 16, 2025, 10:00 AM EDT - 1 year ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Mar 13, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Stockholders to Learn More About the Investigation

Mar 11, 2025, 10:00 AM EDT - 1 year ago

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Investors to Inquire about Securities Investigation

Mar 10, 2025, 4:05 PM EDT - 1 year ago

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 24, 2025, 5:45 AM EST - 1 year ago

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU

Feb 23, 2025, 9:27 AM EST - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Feb 20, 2025, 1:28 PM EST - 1 year ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBU

Feb 19, 2025, 10:22 AM EST - 1 year ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Feb 15, 2025, 3:04 PM EST - 1 year ago

CRBU Deadline: Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their Rights

Jidane Apr. 3 at 1:42 PM

$CRBU He has come again and just spit anything here.

0 · Reply

HughGeez Apr. 3 at 12:51 PM

0 · Reply

HughGeez Apr. 3 at 12:43 PM

$CRBU The funding issue is already certainly built into the extremely low price of this stock. The announcement of a solid funding partner will only contribute to the rise of CRBU.

0 · Reply

Peterson28 Apr. 3 at 1:12 AM

$CRBU Still haven’t figured out the funding issue. One quarter missed already.

0 · Reply

OfficialStocktwitsUser Apr. 2 at 1:33 PM

0 · Reply

CRSPbacon Apr. 1 at 2:47 AM

$CRBU

0 · Reply

StocksGoddess Mar. 31 at 8:39 PM

$CRBU will rise tomorrow again.

0 · Reply

hughbeefman69 Mar. 31 at 5:49 PM

$CRBU Whatcha mean by this exactly? New to checking out this stock, seems like a quality company with some pretty epic recent news...?

1 · Reply

CebuCity Mar. 31 at 4:10 PM

$CRBU Just looking for a hand out...

0 · Reply

Peterson28 Mar. 31 at 3:52 PM

$CRBU Typical price action. Wall Street just hates the stock. Likely flat by end of the day.

0 · Reply

Windytimes Mar. 31 at 3:49 PM

$CRBU shorties love this stock… just wow

0 · Reply

GamblingFerret Mar. 31 at 1:45 PM

$CRBU Step 1 out of 2 for outlicensing done (FDA alignment). Next ist follow-up data in May with potential outlicensing of CB11 in June to finance CB10 phase 3.

1 · Reply

notreload_ai Mar. 31 at 1:36 PM

$CRBU stock surges after FDA grants RMAT designation to CB-011, its off-the-shelf allogeneic CAR-T for multiple myeloma. Phase 1 data: 92% ORR, 75% complete response in BCMA-naïve patients. More data expected 2026. https://notreload.xyz/xy/caribou-crbu-jumps-on-fda-rmat-for-cb-011-car-t/

0 · Reply

STACKD0E Mar. 31 at 1:33 PM

$CRBU $AKTS 🙃✨

0 · Reply

ChicagoJoe20 Mar. 31 at 12:55 PM

$CRBU well, well. The long patience is bearing fruit.

0 · Reply

Sumner36 Mar. 31 at 12:18 PM

$CRBU that $8 valuation is starting to look pretty good, fellow patient kings. 👑

1 · Reply

DARKP00L Mar. 31 at 12:14 PM

$CRBU 08:02 on Mar. 31 2026 Caribou Biosciences Receives FDA's Regenerative Medicine Advanced Therapy Designation To CB-011 For Relapsed Or Refractory Multiple Myeloma #tradeideas

0 · Reply

Stock_Catcher Mar. 31 at 12:00 PM

$CRBU Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy

0 · Reply

RocroBio Mar. 26 at 7:33 PM

$CRBU model just flagged a long signal. forecasting +10% in 14 sessions to $2.10. price is tracking the forecast almost perfectly since the Jan bottom. CI: [0.92%, 19.83%] 📈 Link in bio

0 · Reply

StocksGoddess Mar. 26 at 6:53 PM

$CRBU

0 · Reply

Sumner36 Mar. 26 at 2:42 PM

$CRBU https://www.marketbeat.com/instant-alerts/caribou-biosciences-nasdaqcrbu-stock-rating-upgraded-by-truist-financial-2026-03-26/

0 · Reply

pleasemoney Mar. 24 at 11:36 PM

$CRBU crab

0 · Reply

Market Cap	187.48M
Revenue (ttm)	11.16M
Net Income (ttm)	-148.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,327.33%
Debt to Equity Ratio	0.00

Volume	1,063,800
Avg Vol	1,239,260
Day's Range	N/A - N/A
Shares Out	96.64M
Stochastic %K	72%
Beta	2.46
Analysts	Strong Sell
Price Target	$18.33